# Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)

> **NCT02054793** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Emmanuel Antonarakis, MD**

## Conditions studied

- Prostate Cancer
- Castration-resistant Prostate Cancer

## Interventions

- **DRUG:** Itraconazole
- **DRUG:** Orteronel

## Key facts

- **NCT ID:** NCT02054793
- **Lead sponsor:** Emmanuel Antonarakis, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-06
- **Primary completion:** 2015-06
- **Final completion:** 2016-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was never able to open due to lack of funding from the pharmaceutical company.
- **Last updated:** 2014-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02054793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02054793, "Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02054793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*